	Label	Description
	blood serum Anatomy (Entity type)	The portion of blood plasma that excludes clotting factors.
	mammary gland Anatomy (Entity type)	A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only...
	G39188ZX Compound (Entity type)	type="BaseComposition" mass="1396.48625091" permass="1760.89315273" monosaccharides="8" is_motif="Fa...
	G48414YA Compound (Entity type)	type="Composition" mass="2222.78300589" permass="2769.39335862" monosaccharides="11" is_motif="False...
	IKIP HUMAN Protein (Entity type)	Inhibitor of nuclear factor kappa-B kinase-interacting protein
	q70uq0-1 144asn 144asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	q70uq0-1 328asn 328asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

blood serum

The portion of blood plasma that excludes clotting factors.

mammary gland

A specialized accessory gland of the skin of mammals that secretes milk. The gland is typically only...

G39188ZX

type="BaseComposition" mass="1396.48625091" permass="1760.89315273" monosaccharides="8" is_motif="Fa...

G48414YA

type="Composition" mass="2222.78300589" permass="2769.39335862" monosaccharides="11" is_motif="False...

IKIP HUMAN

Inhibitor of nuclear factor kappa-B kinase-interacting protein

q70uq0-1 144asn 144asn defined go:0006486 go:0006487

A Post Translational Modification

q70uq0-1 328asn 328asn defined go:0006486 go:0006487

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.